| HALLMARK EPITHELIAL MESENCHYMAL TRANSITION |
0.00 |
0.00 |
0.00 |
| HALLMARK MYC TARGETS V2 |
0.00 |
0.00 |
0.00 |
| HALLMARK UNFOLDED PROTEIN RESPONSE |
0.00 |
0.00 |
0.00 |
| HALLMARK TNFA SIGNALING VIA NFKB |
0.00 |
0.00 |
0.00 |
| HALLMARK INFLAMMATORY RESPONSE |
0.00 |
0.01 |
0.03 |
| HALLMARK IL2 STAT5 SIGNALING |
0.00 |
0.01 |
0.06 |
| HALLMARK MTORC1 SIGNALING |
0.00 |
0.02 |
0.08 |
| HALLMARK WNT BETA CATENIN SIGNALING |
0.01 |
0.02 |
0.10 |
| HALLMARK ALLOGRAFT REJECTION |
0.01 |
0.03 |
0.16 |
| HALLMARK P53 PATHWAY |
0.00 |
0.05 |
0.32 |
| HALLMARK KRAS SIGNALING DN |
0.05 |
0.07 |
0.47 |
| HALLMARK MYOGENESIS |
0.05 |
0.12 |
0.66 |
| HALLMARK HYPOXIA |
0.05 |
0.18 |
0.84 |
| HALLMARK KRAS SIGNALING UP |
0.11 |
0.19 |
0.89 |
| HALLMARK UV RESPONSE DN |
0.12 |
0.27 |
0.97 |
| HALLMARK CHOLESTEROL HOMEOSTASIS |
0.17 |
0.26 |
0.97 |
| HALLMARK ANDROGEN RESPONSE |
0.17 |
0.28 |
0.98 |
| HALLMARK PI3K AKT MTOR SIGNALING |
0.18 |
0.28 |
0.99 |
| HALLMARK APICAL JUNCTION |
0.15 |
0.28 |
0.99 |
| HALLMARK COMPLEMENT |
0.19 |
0.31 |
0.99 |
